/
GNTA
$1.30+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$62.7M
48M shares
52-week range
$0.55 – $10.00
8% from low
Exchange
NASDAQ
ADRC
Change$-9.70
Genenta Science S.p.A. American Depositary Shares
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
www.genenta.com- Employees
- 9
- IPO / List date
- Dec 15, 2021
Held by traders on TradeandTell
No one on the platform currently holds GNTA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GNTA as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2011-02-18 | 1-for-50reverse |
| 2009-07-13 | 1-for-50reverse |
Recent trades on TradeandTell
No one on the platform has traded GNTA yet.
